487 results on '"Pediatric Crohn's disease"'
Search Results
452. Prevention of recurrence by mesalamine (Pentasa) in pediatric Crohn's disease A multicentric double blind trial
453. 22 PS Omega-3 fatty acids supplementation in pediatric Crohn's disease Italian multicentric study
454. Pediatric Crohn's disease: Risk factors for postoperative recurrence
455. Allergic reactions to infliximab retreatment are decreased in pediatric Crohn's disease (CD) patients compared to adults
456. The use of infliximab in pediatric Crohn's disease
457. Parenting stress and family environment as predictors of treatment outcome in pediatric Crohn's disease
458. Health related quality of life (HRQOL) in pediatric crohn's disease
459. Collaborative experience of open-label infliximab in refractory pediatric Crohn's disease
460. Coping and quality of life in pediatric Crohn's disease
461. Distinct mucosal T cell phenotypes in early and late pediatric Crohn's disease (CD): Increased naive T cells are found in late, but not early CD
462. METHOTREXATE: AN ALTERNATIVE TREATMENT IN PEDIATRIC CROHN'S DISEASE
463. COLLABORATIVE EXPERIENCE OF OPEN-LABEL INFLIXIMAB IN REFRACTORY PEDIATRIC CROHN'S DISEASE
464. LACTOBACILLUS GG (L-GG) IMPROVES PEDIATRIC CROHN'S DISEASE ACTIVITY INDEX (PCDAI) IN CHILDREN WITH CROHN'S DISEASE
465. Current therapy of pediatric Crohn's disease.
466. Adalimumab for the treatment of pediatric Crohn's disease.
467. Double-positive anti-saccharomyces test is 100% disease-specific for pediatric Crohn's disease
468. Doppler sonographic assessment of vessel density in the diseased bowel in pediatric Crohn's disease
469. 6-mercaptopurine (6MP)+ prednisone therapy for newly diagnosed pediatric Crohn's disease (CD): a prospective, multicenter, placebo-controlled clinical trial
470. Crohn's disease and growth deficiency in children and adolescents.
471. SPECIFICITY OF A NEW SEROLOGICAL TEST FOR PEDIATRIC CROHN'S DISEASE
472. CYCLICAL EXCLUSIVE SEMI-ELEMENTAL DIET THERAPY NORMALIZES GROWTH AND DECREASES RELAPSE RATE IN PEDIATRIC CROHN'S DISEASE
473. STAT3 Regulation of Mucosal Inflammation in Pediatric Crohn’s Disease and Murine Colitis
474. Factors That Determine Risk for Surgery in Pediatric Patients With Crohn's Disease.
475. 83 WHOLE BODY COMPOSITION AFTER ENTERAL NUTRITIONAL (EN) THERAPY IN PEDIATRIC CROHN'S DISEASE
476. 9 RELAPSE PREVENTION/GROWTH ENHANCEMENT IN PEDIATRIC CROHN'S DISEASE: MULTICENTER RANDOMIZED CONTROLLED TRIAL OF INTERMITTENT ENTERAL NUTRITION VERSUS ALTERNATE DAY PREDNISONE
477. 86 ORAL MESALAMINE (PENTASA) AS MAINTENANCE TREATMENT IN PEDIATRIC CROHN'S DISEASE PATIENTS WITH RECENTLY INDUCED REMISSION. A MULTICENTER PLACEBO-CONTROLLED STUDY
478. Fecal α1-antitrypsin (α1-AT): A marker of inflammation in pediatric Crohn's disease (CD)
479. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
480. Development and Validation of a Pediatric Crohnʼs Disease Activity Index
481. Life-threatening lower gastrointestinal hemorrhage in pediatric Crohn's disease.
482. Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up.
483. [Untitled]
484. [Untitled]
485. Single-Cell Sequencing of Developing Human Gut Reveals Transcriptional Links to Childhood Crohn's Disease
486. Single-Cell Sequencing of Developing Human Gut Reveals Transcriptional Links to Childhood Crohn's Disease
487. Enteral nutrition and microflora in pediatric Crohn's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.